Dendritic Cell Vaccination in Combination With Docetaxel for Patients With Cancer Prostate - a Randomized Phase II Study.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms DCProst
- 16 Aug 2016 Biomarkers information updated
- 21 Apr 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-001602-10).
- 07 Oct 2011 New trial record